Physician
Aurora Concepts, PLLC
Aurora Concepts, PLLC was paid $1.46M by Medicaid between May 2018 and Dec 2024, across 89 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoAURORA CONCEPTS, PLLC
CENTER, TX 75935
CENTER, TX 75935
33aNPI1750779542assigned 12/31/2014
33bProvider typeFamily Medicine Physician
28Total paid$1.46M
24GClaims81,203
24DCodes billed89
24AFirst – last monthMay 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#73 of 1,204
Median peer was paid$31K
This provider vs. median48×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 261 | $1K | |
| 2019 | 321 | $2K | |
| 2020 | 5,631 | $102K | |
| 2021 | 20,204 | $363K | |
| 2022 | 18,517 | $443K | |
| 2023 | 22,044 | $342K | |
| 2024incomplete | 14,225 | $210K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 13,891 | 11,939 | $436K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 11% | 15,586 | 9,082 | $165K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 11% | 1,227 | 1,185 | $165K |
| 87428 | 9.0% | 2,764 | 2,538 | $132K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.4% | 2,306 | 2,044 | $94K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.6% | 1,420 | 1,306 | $67K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.2% | 2,503 | 2,091 | $61K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.8% | 798 | 718 | $56K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.3% | 648 | 634 | $48K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.1% | 422 | 416 | $30K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.8% | 1,983 | 1,902 | $26K |
| 99000 | 1.6% | 2,810 | 2,523 | $24K |
77 more codes
| 90619 | 1.1% | 2,059 | $16K | |
| 96112 | 1.0% | 151 | $15K | |
| 90461 | <1% | 2,070 | $14K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,188 | $13K |
| 0001A | <1% | 335 | $10K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 308 | $10K |
| 0002A | <1% | 288 | $8K | |
| 87430 | <1% | 568 | $7K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 348 | $7K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 895 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 532 | $6K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 98 | $6K |
| 0012A | <1% | 426 | $5K | |
| 99384 | <1% | 49 | $4K | |
| 0011A | <1% | 513 | $4K | |
| 91322 | <1% | 123 | $3K | |
| 0071A | <1% | 64 | $2K | |
| 0004A | <1% | 77 | $2K | |
| 90674 | <1% | 643 | $2K | |
| 0072A | <1% | 50 | $2K | |
| 81025 | <1% | 316 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 63 | $2K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 41 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 26 | $2K |
| 90480 | <1% | 169 | $1K | |
| 87807 | <1% | 119 | $1K | |
| 99383 | <1% | 13 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 15 | $965.64 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 83 | $939.77 |
| 81003 | <1% | 410 | $713.86 | |
| 0124A | <1% | 31 | $680.00 | |
| 81002 | <1% | 265 | $650.84 | |
| 90620 | <1% | 237 | $614.36 | |
| 90734 | <1% | 1,784 | $604.46 | |
| 90661 | <1% | 387 | $443.92 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 365 | $308.50 |
| 90677 | <1% | 20 | $271.95 | |
| 0003A | <1% | 71 | $200.00 | |
| 96160 | <1% | 131 | $155.73 | |
| 99324 | <1% | 195 | $154.32 | |
| 91320 | <1% | 39 | $131.10 | |
| 90694 | <1% | 29 | $64.16 | |
| 0013A | <1% | 12 | $50.00 | |
| 90715 | <1% | 2,623 | $32.93 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 26 | $31.83 |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 157 | $24.19 |
| 91300 | <1% | 619 | $0.62 | |
| 91301 | <1% | 326 | $0.45 | |
| 90686 | <1% | 2,219 | $0.22 | |
| 91307 | <1% | 114 | $0.21 | |
| 90651 | <1% | 588 | $0.10 | |
| 90716 | <1% | 130 | $0.02 | |
| 90670 | <1% | 64 | $0.01 | |
| 90696 | 0% | 280 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 1,928 | $0.00 |
| 99050 | 0% | 81 | $0.00 | |
| 3074F | 0% | 492 | $0.00 | |
| 3079F | 0% | 55 | $0.00 | |
| 90744 | 0% | 12 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 19 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 70 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 144 | $0.00 |
| 90656 | 0% | 37 | $0.00 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 39 | $0.00 |
| 90698 | 0% | 14 | $0.00 | |
| 90710 | 0% | 358 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 7,722 | $0.00 |
| 90707 | 0% | 114 | $0.00 | |
| 90633 | 0% | 365 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 33 | $0.00 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 45 | $0.00 |
| 3078F | 0% | 297 | $0.00 | |
| 99334 | 0% | 23 | $0.00 | |
| 90700 | 0% | 92 | $0.00 | |
| 91312 | 0% | 16 | $0.00 | |
| 90653 | 0% | 79 | $0.00 | |
| 90713 | 0% | 58 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBARNES, ANITA (MEMBER/MANAGER)